Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-108176
Filing Date
2025-08-13
Accepted
2025-08-13 17:29:13
Documents
14
Effectiveness Date
2025-08-13

Document Format Files

Seq Description Document Type Size
1 S-8 ck0001774857-20250813.htm S-8 147211
2 EX-5.1 ck0001774857-ex5_1.htm EX-5.1 23946
3 EX-23.1 ck0001774857-ex23_1.htm EX-23.1 3355
4 EX-FILING FEES ck0001774857_exfilingfees.htm   iXBRL EX-FILING FEES 58859
  Complete submission text file 0000950170-25-108176.txt   371131

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT ck0001774857_exfilingfees_htm.xml XML 11438
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Filer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289592 | Film No.: 251213128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)